A detailed history of Brewin Dolphin LTD transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 112 shares of CDMO stock, worth $1,373. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112
Previous 112 -0.0%
Holding current value
$1,373
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$20.7 - $34.18 $2,318 - $3,828
112 New
112 $3,000
Q3 2021

Nov 09, 2023

SELL
$19.05 - $28.32 $24,479 - $36,391
-1,285 Reduced 91.98%
112 $2.42 Million
Q1 2021

Nov 09, 2023

SELL
$11.86 - $21.77 $17,374 - $31,893
-1,465 Reduced 51.19%
1,397 $25.5 Million
Q2 2019

Nov 09, 2023

BUY
$3.43 - $5.6 $4,407 - $7,195
1,285 Added 81.48%
2,862 $16 Million
Q2 2018

Nov 09, 2023

BUY
$3.1 - $3.93 $4,541 - $5,757
1,465 Added 1308.04%
1,577 $6.18 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $762M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.